These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 26651257)
21. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552 [TBL] [Abstract][Full Text] [Related]
22. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587 [TBL] [Abstract][Full Text] [Related]
23. The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract. Bornschein J; Bird-Lieberman EL; Malfertheiner P Dig Dis; 2019; 37(5):381-393. PubMed ID: 30970344 [TBL] [Abstract][Full Text] [Related]
24. Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? Bazuro GE; Torino F; Gasparini G; Capurso L Minerva Gastroenterol Dietol; 2008 Dec; 54(4):429-44. PubMed ID: 19047983 [TBL] [Abstract][Full Text] [Related]
25. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Kwon YH; Heo J; Lee HS; Cho CM; Jeon SW Aliment Pharmacol Ther; 2014 Mar; 39(6):609-18. PubMed ID: 24461252 [TBL] [Abstract][Full Text] [Related]
34. [Gastrointestinal manifestations of Helicobacter pylori infection in adults: from gastritis to gastric cancer]. Delchier JC Presse Med; 2008 Mar; 37(3 Pt 2):519-24. PubMed ID: 18261873 [TBL] [Abstract][Full Text] [Related]
35. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Malfertheiner P; Sipponen P; Naumann M; Moayyedi P; Mégraud F; Xiao SD; Sugano K; Nyrén O; Am J Gastroenterol; 2005 Sep; 100(9):2100-15. PubMed ID: 16128957 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer. Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609 [TBL] [Abstract][Full Text] [Related]
37. Chemoprevention Against Gastric Cancer. Shah SC; Peek RM Gastrointest Endosc Clin N Am; 2021 Jul; 31(3):519-542. PubMed ID: 34053637 [TBL] [Abstract][Full Text] [Related]
39. Screening of gastric cancer in Asia. Sugano K Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):895-905. PubMed ID: 26651251 [TBL] [Abstract][Full Text] [Related]
40. Review article: the epidemiology and prevention of gastric cancer. Fock KM Aliment Pharmacol Ther; 2014 Aug; 40(3):250-60. PubMed ID: 24912650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]